IPCA LABORATORIES
|
The Current P/S Ratio of IPCA LABORATORIES is 4.74.
| Share Price | ₹1,889.9 | Aug 18,2026 |
| Market Cap | ₹47,945.5 Cr | |
| Sales-TTM | ₹10,125.6 Cr | TTM-Consolidated Results |
| Price/Sales | 4.74x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of IPCA LABORATORIES
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹47,945.5 Cr] as on Aug 18,2026
(/) Sales [ ₹10,125.6 Cr] based on TTM-Consolidated Results
(=) P/S Ratio [ 4.74x ]
Thus, for IPCA LABORATORIES , the investors are currently willing to pay '4.74 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of IPCA LABORATORIES !
The chart below summarizes the trend in P/S Ratio of IPCA LABORATORIES over the last five years.
Historical PS (Price/Sales) ratio chart of IPCA LABORATORIES
PS Ratio Performance Analysis for IPCA LABORATORIES
- IPCA LABORATORIES 's p/e ratio for fiscal years ending Mar2026 to Mar2022 averaged 4.11x.
- IPCA LABORATORIES 's operated at median p/e ratio of 4.24x from fiscal years ending March 2018 to 2022.
- Looking back at the last 5 fiscal years, IPCA LABORATORIES 's p/e ratio peaked in Mar2022 at 4.64x.
- IPCA LABORATORIES 's p/e ratio hit its five-year low in Mar2023 of 3.31x.
How does IPCA LABORATORIES 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| IPCA LABORATORIES | 10,125.6 | 4.74 | 47,945.5 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 59,910.5 | 7.51 | 450,211.0 |
| DIVIS LABORATORIES LTD | 11,230.0 | 20.33 | 228,303.0 |
| TORRENT PHARMACEUTICALS LTD | 15,723.0 | 12.04 | 189,233.0 |
| CIPLA LTD | 28,324.4 | 4.08 | 115,672.0 |
| DR REDDYS LABORATORIES LTD | 33,227.9 | 2.97 | 98,533.5 |
| MANKIND PHARMA LTD | 14,737.9 | 6.70 | 98,706.0 |
| LUPIN LTD | 29,966.6 | 3.39 | 101,735.0 |
| ZYDUS LIFESCIENCES LTD | 28,591.7 | 3.90 | 111,421.0 |
| AUROBINDO PHARMA LTD | 34,935.3 | 2.70 | 94,272.8 |
| LAURUS LABS LTD | 7,269.6 | 13.49 | 98,034.2 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs IPCA LABORATORIES 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.70x |
| Max industry PS | 20.33x |
| Median industry PS | 4.74x |
| Average industry PS | 7.44x |
You may also like the below Video Courses